Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib.

Marcé, Sílvia; Xicoy, Blanca; García, Olga; Cabezón, Marta; Estrada, Natalia; Vélez, Patricia; Boqué, Concepción; Sagüés, Miguel; Angona, Anna; Teruel-Montoya, Raúl; Ferrer-Marín, Francisca; Amat, Paula; Hernández-Boluda, Juan Carlos; Ibarra, Mariana M; Anguita, Eduardo; Cortés, Montserrat; Fernández-Ruiz, Andrés; Fontanals, Sandra; Zamora, Lurdes

Marcé, Sílvia; Xicoy, Blanca; García, Olga; Cabezón, Marta; Estrada, Natalia; Vélez, Patricia; Boqué, Concepción; Sagüés, Miguel; Angona, Anna; Teruel-Montoya, Raúl; Ferrer-Marín, Francisca; Amat, Paula; Hernández-Boluda, Juan Carlos; Ibarra, Mariana M; Anguita, Eduardo; Cortés, Montserrat; Fernández-Ruiz, Andrés; Fontanals, Sandra; Zamora, Lurdes.

Afiliação

Marcé S; Myeloid Neoplasms Group, Hematology Department, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain.
Xicoy B; Myeloid Neoplasms Group, Hematology Department, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain.
García O; Myeloid Neoplasms Group, Hematology Department, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain.
Cabezón M; Myeloid Neoplasms Group, Hematology Department, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain.
Estrada N; Myeloid Neoplasms Group, Hematology Department, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain.
Vélez P; Hematology Department, ICO Hospitalet-Hospital Duran y Reynals, 08908 l'Hospitalet de Llobregat, Spain.
Boqué C; Hematology Department, ICO Hospitalet-Hospital Duran y Reynals, 08908 l'Hospitalet de Llobregat, Spain.
Sagüés M; Hematology Department, ICO Girona-Hospital Josep Trueta, 17007 Girona, Spain.
Angona A; Hematology Department, ICO Girona-Hospital Josep Trueta, 17007 Girona, Spain.
Teruel-Montoya R; Hematology-Oncology Department, Hospital General Universitario Morales Meseguer-CIBERER, UCAM, 30008 Murcia, Spain.
Ferrer-Marín F; Hematology-Oncology Department, Hospital General Universitario Morales Meseguer-CIBERER, UCAM, 30008 Murcia, Spain.
Amat P; Hematology Department, Hospital Clínico Universitario-INCLIVA de Valencia, 46010 Valencia, Spain.
Hernández-Boluda JC; Hematology Department, Hospital Clínico Universitario-INCLIVA de Valencia, 46010 Valencia, Spain.
Ibarra MM; Hematology Department, Hospital Clínico San Carlos (HCSC), Instituto de Medicina de Laboratorio (IML), Instituto de Investigación Sanitaria San Carlos (IdISSC), Department of Medicine, Universidad Complutense de Madrid (UCM), 28040 Madrid, Spain.
Anguita E; Hematology Department, Hospital Clínico San Carlos (HCSC), Instituto de Medicina de Laboratorio (IML), Instituto de Investigación Sanitaria San Carlos (IdISSC), Department of Medicine, Universidad Complutense de Madrid (UCM), 28040 Madrid, Spain.
Cortés M; Hematology Department, Hospital General de Granollers, 08402 Granollers, Spain.
Fernández-Ruiz A; Hematology Department, ICO Hospitalet-Hospital Duran y Reynals, 08908 l'Hospitalet de Llobregat, Spain.
Fontanals S; Pharmaceutics Department, ICO Hospitalet-Hospital Duran y Reynals, 08908 l'Hospitalet de Llobregat, Spain.
Zamora L; Myeloid Neoplasms Group, Hematology Department, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain.